1. DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network.
- Author
-
Hammond CM, Bao H, Hendriks IA, Carraro M, García-Nieto A, Liu Y, Reverón-Gómez N, Spanos C, Chen L, Rappsilber J, Nielsen ML, Patel DJ, Huang H, and Groth A
- Subjects
- Cell Line, Tumor, Chromatin, Chromatin Assembly and Disassembly, DNA Replication, HSP40 Heat-Shock Proteins physiology, HSP70 Heat-Shock Proteins metabolism, HeLa Cells, Histone Chaperones physiology, Histones metabolism, Humans, Minichromosome Maintenance Complex Component 2 metabolism, Models, Molecular, Molecular Chaperones metabolism, Nucleosomes, Protein Binding, Proteomics methods, HSP40 Heat-Shock Proteins metabolism, Histone Chaperones metabolism
- Abstract
From biosynthesis to assembly into nucleosomes, histones are handed through a cascade of histone chaperones, which shield histones from non-specific interactions. Whether mechanisms exist to safeguard the histone fold during histone chaperone handover events or to release trapped intermediates is unclear. Using structure-guided and functional proteomics, we identify and characterize a histone chaperone function of DNAJC9, a heat shock co-chaperone that promotes HSP70-mediated catalysis. We elucidate the structure of DNAJC9, in a histone H3-H4 co-chaperone complex with MCM2, revealing how this dual histone and heat shock co-chaperone binds histone substrates. We show that DNAJC9 recruits HSP70-type enzymes via its J domain to fold histone H3-H4 substrates: upstream in the histone supply chain, during replication- and transcription-coupled nucleosome assembly, and to clean up spurious interactions. With its dual functionality, DNAJC9 integrates ATP-resourced protein folding into the histone supply pathway to resolve aberrant intermediates throughout the dynamic lives of histones., Competing Interests: Declaration of interests C.M.H., D.J.P., H.H., and A.G. are inventors on a filed patent application covering the therapeutic targeting of TONSL for cancer therapy. A.G. is a co-founder and chief scientific officer (CSO) of Ankrin Therapeutics. A.G. is a member of Molecular Cell’s scientific advisory board., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF